Edgewise Therapeutics Inc. Common Stock vs Cactus Inc. Class A Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while Cactus Inc. Class A Common Stock trades at $62.37 (market cap $5.02B). The key difference: Cactus Inc. Class A Common Stock is the larger of the two by market cap, and Cactus Inc. Class A Common Stock pays a 0.96% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Cactus Inc. Class A Common Stock for 0 Days on average.
| EWTX | WHD | |
|---|---|---|
Market Cap | $4.02B | $5.02B |
Volume | 1,446,128 | 804,573 |
Sector | Health | Energy |
52-Week High | $48.35 | $73.73 |
52-Week Low | $14.89 | $35.26 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $4.71B |
Dividend Yield | — | 0.96% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Cactus Inc. designs, manufactures, and rents wellhead and pressure control equipment for oil and gas drilling, completion, and production, operating under the Cactus Wellhead brand.
Read more on WHD →